Pasithea Therapeutics Corp.
KTTA
$0.9258
-$0.0302-3.16%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -5.93% | 22.41% | -0.14% | 23.52% | -39.74% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -46.38% | 10.99% | -38.52% | 167.75% | -170.89% |
| Change in Net Operating Assets | 190.88% | 5.70% | 43.61% | -164.88% | 1,018.01% |
| Cash from Operations | 21.71% | 22.74% | 6.53% | -10.64% | -47.12% |
| Capital Expenditure | -- | -- | -- | -- | -100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 98.18% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 200.00% |
| Cash from Investing | -- | -- | -- | -- | 219.24% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 100.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.53% | -- | -- | -- | -- |
| Cash from Financing | -100.52% | -- | -- | -- | 100.00% |
| Foreign Exchange rate Adjustments | 203.69% | -834.48% | -383.33% | -119.35% | 172.09% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -274.97% | 134.48% | 6.48% | -32.83% | 53.93% |